11/7/2008Sanofi-Aventis, Pfizer discontinue obesity drug trials

11/3/2008Tianyao denies Pfizer acquisition rumor

10/27/2008Industry voices: creating a center of excellence in China

10/17/2008Medicilon and MPI opens new preclinical research facility in Shanghai ...

10/9/2008Health Minister Chen Zhu meets Pfizer delegation

10/7/2008Pfizer realigns its business units to fit the changing environment

10/2/2008Market Snapshot - Chinese CRO market size estimate

10/1/2008Pfizer is to shift R&D focus

9/18/2008New PwC report finds changing nature pharma outsourcing in Asia

9/17/2008Chinese Pre-clinical Safety Data: Is the FDA ready?

9/9/2008Speculation: Pfizer may seek to take over Bayer

9/5/2008Acesys and Provid form alliance for medicinal chemistry services

9/3/2008U.S. judge rules against Chinese drug firms in Serenex corporate espio...

9/3/2008Pfizer, Medivation enter global drug pact

9/2/2008China''s clinical research boom bottlenecked by government''s reluctan...

8/22/2008The Rise of China''s Contract Research Sector: Evaluating Quality and ...

8/7/2008Global drug industry restructure fuels R+D outsourcing growth in China...

8/5/2008Study: Pfizer may drop to No.6 by sales in just six years

7/14/2008Tigermed Receives US$5 Million Venture Capital Funding

6/20/2008US Drug Companies under Fire for Outsourcing Manufacturing

6/13/2008Pfizer and Baxter Outsource China Marketing of Selected Oncology Drugs...

6/11/2008Pfizer Eyes Tianjin Tianyao for Acquisition?

6/11/2008New Study: The Globalization of Pharmaceutical Innovation

6/2/2008Study Questions Quality of China's Clinical Trials

5/27/2008IMS: Pharma Outsourcing on the Rise

5/13/2008Pfizer Donates CNY 10 Million to Earthquake Victims and Relief Efforts...

4/15/2008India Beats China in Race for Asia's Top Clinical Spot

4/9/2008Pfizer Loses "Wei Ge" Trademark Lawsuit

4/4/2008CROs in Asia Pacific to Experience Sharp Growth

4/1/2008SFDA Issues No.129 Announcement of Drug Administrative protection

Page:26/27 Total number of articles:788: [First][<<] [23] [24] [25] [26] [27] [>>] [End]